That's cool. You're welcome to overlook the November R&D clearly...

That's cool. You're welcome to overlook the November R&D clearly stated on the same page, plus the likely sizeable amounts of options exercised as the SP continues to increase.

Also that we wouldn't ever see another scary "CR" here. It should be blatantly obviously to every Nor holder that if funds were needed next year (absolutely not "urgent", or any likelihood at all), it would be the same as the previous rounds of notes that the directors have been so keen on.

I might flick in $25k in the new year to up the balance a little if you are genuinely concerned.

Happy to have a differing opinion though. Hopefully you now have more of an understanding of where things are at.. and maybe you would now be more confident of investing in Nor.

I would personally assume all the recent off screen buyers don't have concerns where it's heading, and are likely very confident of the companies position, and how much upside there is from such a low $10m MC.

Best of luck mate.